Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C L EVANS

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Urology|December 31, 1997
Molecular forms of prostate-specific antigen and human kallikrein 2 (hK2) in urine are not clinically useful for early detection and staging of prostate cancerJ Pannek, H G Rittenhouse, C L Evans, et al.
Urology|June 4, 1998
Development of monoclonal antibodies specific for human glandular kallikrein (hK2): development of a dual antibody immunoassay for hK2 with negligible prostate-specific antigen cross-reactivityJ A Finlay, C L Evans, J R Day, et al.
Clinical Chemistry|June 28, 2001
Development of a dual monoclonal antibody immunoassay for total human kallikrein 2J A Finlay, J R Day, C L Evans, et al.
Cancer Research|September 18, 2001
A truncated precursor form of prostate-specific antigen is a more specific serum marker of prostate cancerS D Mikolajczyk, K M Marker, L S Millar, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Urology|December 31, 1997
Molecular forms of prostate-specific antigen and human kallikrein 2 (hK2) in urine are not clinically useful for early detection and staging of prostate cancerJ Pannek, H G Rittenhouse, C L Evans, et al.
Urology|June 4, 1998
Development of monoclonal antibodies specific for human glandular kallikrein (hK2): development of a dual antibody immunoassay for hK2 with negligible prostate-specific antigen cross-reactivityJ A Finlay, C L Evans, J R Day, et al.
Clinical Chemistry|June 28, 2001
Development of a dual monoclonal antibody immunoassay for total human kallikrein 2J A Finlay, J R Day, C L Evans, et al.
Cancer Research|September 18, 2001
A truncated precursor form of prostate-specific antigen is a more specific serum marker of prostate cancerS D Mikolajczyk, K M Marker, L S Millar, et al.
Pageof 4